This Leading Diabetes Stock Just Launched Into A Profit-Taking Zone

ALLISON GATLIN
This Leading Diabetes Stock Just Launched Into A Profit-Taking Zone

Dexcom stock rocketed to a record high Friday after the diabetes treatment outlet topped its pre-announced fourth-quarter revenue by $6 million. Analysts are bullish on the stock.